Clinical Trial Update: A Study of PF-06438179 (Infliximab-Pfizer) and Infliximab in Combination With Methotrexate in Subjects With Active Rheumatoid Arthritis (REFLECTIONS B537-02). [Phase 3]

View source ↗

Summary

Phase 3 REFLECTIONS B537-02 trial evaluating PF-06438179 (Pfizer's infliximab) in combination with methotrexate versus infliximab with methotrexate in active rh…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Rheumatoid Arthritis

Drugs mentioned

• Infliximab (infliximab)
• PF-06438179 (Infliximab-Pfizer) (infliximab)

Snippet

Sponsor: Pfizer | Conditions: Rheumatoid Arthritis | Phase 3 | Status: COMPLETED | Results posted: 2017-09-11